BiotechTube
Home/Neuren Pharmaceuticals/Jon Pilcher
JP

Jon Pilcher

Chief Executive Officer/Managing Director

Neuren Pharmaceuticals

Therapeutic Areas

Neurodevelopmental DisordersNeurodegenerative Disorders

Neuren Pharmaceuticals Pipeline

DrugIndicationPhase
DAYBUE® (trofinetide)Rett SyndromeApproved
NNZ-2591Phelan-McDermid SyndromePhase 2

Leadership Team at Neuren Pharmaceuticals

PD
Patrick Davies
Non-Executive Chair
DA
Dianne Angus
Non-Executive Director
View full Neuren Pharmaceuticals profile